Article
Activin A Causes Muscle Atrophy through MEF2C-Dependent Impaired Myogenesis
25 Mar 2022
Abstract excerpt
Activin A (ActA) is considered to play a major role in cancer-induced cachexia (CC). Indeed, circulating ActA levels are elevated and predict survival in patients with CC. However, the mechanisms by which ActA mediates CC development and in particular skeletal muscle (SM) atrophy in humans are not yet fully understood. In this work, we aimed to investigate the effects of ActA on human SM and in mouse models of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
